Development Through Deployment
Osseon Therapeutics provides improved bone cement composite and complementary bone cement delivery devices for treating osteoporosis (OSP), osteo-trauma, and other bone diseases. By improving treatments for these ubiquitous maladies, Osseon aims to be the principal provider of alternative minimally invasive treatment for bone diseases. The company’s patent-pending novel material and delivery method are designed to provide cost-competitive and clinically superior outcomes. Osseon is progressing towards initial product launch.